Pertussis-Associated Pneumonia in Infants and Children From Low- and Middle-Income Countries Participating in the PERCH Study

Breanna Barger-Kamate, Maria Deloria Knoll, E Wangeci Kagucia, Christine Prosperi, Henry C Baggett, W Abdullah Brooks, Daniel R Feikin, Laura L Hammitt, Stephen R C Howie, Orin S Levine, Shabir A Madhi, J Anthony G Scott, Donald M Thea, Tussanee Amornintapichet, Trevor P Anderson, Juliet O Awori, Vicky L Baillie, James Chipeta, Andrea N DeLuca, Amanda J Driscoll, Doli Goswami, Melissa M Higdon, Lokman Hossain, Ruth A Karron, Susan Maloney, David P Moore, Susan C Morpeth, Lawrence Mwananyanda, Ogochukwu Ofordile, Emmanuel Olutunde, Daniel E Park, Samba O Sow, Milagritos D Tapia, David R Murdoch, Katherine L O'Brien, Karen L Kotloff, Pneumonia Etiology Research for Child Health (PERCH) Study Group, Hasan Ashraf, Dilruba Ahmed, Hubert Endtz, Yasmin Jahan, Khalequ Zaman, Peter V Adrian, Azwifarwi Mudau, Locadiah Kuwanda, Michelle J Groome, Martin Antonio, Bernard E Ebruke, Grant Mackenzie, Jessica McLellan, Eunice M Machuka, Arifin Shamsul, Syed M A Zaman, Wei Fu, Mengying Li, Charatdao Bunthi, Pongpun Sawatwong, Pasakorn Akarasewi, Julia Rhodes, Somsak Thamthitiwat, Julie Duncan, James Mwansa, Somwe Wa Somwe, Sidi Kazungu, Alice Kamau, Geoffrey Kwenda, Uma Onwuchekwa, Boubou Tamboura, Mamadou Sylla, Phil Seidenberg, Scott Zeger, Breanna Barger-Kamate, Maria Deloria Knoll, E Wangeci Kagucia, Christine Prosperi, Henry C Baggett, W Abdullah Brooks, Daniel R Feikin, Laura L Hammitt, Stephen R C Howie, Orin S Levine, Shabir A Madhi, J Anthony G Scott, Donald M Thea, Tussanee Amornintapichet, Trevor P Anderson, Juliet O Awori, Vicky L Baillie, James Chipeta, Andrea N DeLuca, Amanda J Driscoll, Doli Goswami, Melissa M Higdon, Lokman Hossain, Ruth A Karron, Susan Maloney, David P Moore, Susan C Morpeth, Lawrence Mwananyanda, Ogochukwu Ofordile, Emmanuel Olutunde, Daniel E Park, Samba O Sow, Milagritos D Tapia, David R Murdoch, Katherine L O'Brien, Karen L Kotloff, Pneumonia Etiology Research for Child Health (PERCH) Study Group, Hasan Ashraf, Dilruba Ahmed, Hubert Endtz, Yasmin Jahan, Khalequ Zaman, Peter V Adrian, Azwifarwi Mudau, Locadiah Kuwanda, Michelle J Groome, Martin Antonio, Bernard E Ebruke, Grant Mackenzie, Jessica McLellan, Eunice M Machuka, Arifin Shamsul, Syed M A Zaman, Wei Fu, Mengying Li, Charatdao Bunthi, Pongpun Sawatwong, Pasakorn Akarasewi, Julia Rhodes, Somsak Thamthitiwat, Julie Duncan, James Mwansa, Somwe Wa Somwe, Sidi Kazungu, Alice Kamau, Geoffrey Kwenda, Uma Onwuchekwa, Boubou Tamboura, Mamadou Sylla, Phil Seidenberg, Scott Zeger

Abstract

Background: Few data exist describing pertussis epidemiology among infants and children in low- and middle-income countries to guide preventive strategies.

Methods: Children 1-59 months of age hospitalized with World Health Organization-defined severe or very severe pneumonia in 7 African and Asian countries and similarly aged community controls were enrolled in the Pneumonia Etiology Research for Child Health study. They underwent a standardized clinical evaluation and provided nasopharyngeal and oropharyngeal swabs and induced sputum (cases only) for Bordetella pertussis polymerase chain reaction. Risk factors and pertussis-associated clinical findings were identified.

Results: Bordetella pertussis was detected in 53 of 4200 (1.3%) cases and 11 of 5196 (0.2%) controls. In the age stratum 1-5 months, 40 (2.3% of 1721) cases were positive, all from African sites, as were 8 (0.5% of 1617) controls. Pertussis-positive African cases 1-5 months old, compared to controls, were more often human immunodeficiency virus (HIV) uninfected-exposed (adjusted odds ratio [aOR], 2.2), unvaccinated (aOR, 3.7), underweight (aOR, 6.3), and too young to be immunized (aOR, 16.1) (all P ≤ .05). Compared with pertussis-negative African cases in this age group, pertussis-positive cases were younger, more likely to vomit (aOR, 2.6), to cough ≥14 days (aOR, 6.3), to have leukocyte counts >20 000 cells/µL (aOR, 4.6), and to have lymphocyte counts >10 000 cells/µL (aOR, 7.2) (all P ≤ .05). The case fatality ratio of pertussis-infected pneumonia cases 1-5 months of age was 12.5% (95% confidence interval, 4.2%-26.8%; 5/40); pertussis was identified in 3.7% of 137 in-hospital deaths among African cases in this age group.

Conclusions: In the postneonatal period, pertussis causes a small fraction of hospitalized pneumonia cases and deaths; however, case fatality is substantial. The propensity to infect unvaccinated infants and those at risk for insufficient immunity (too young to be vaccinated, premature, HIV-infected/exposed) suggests that the role for maternal vaccination should be considered along with efforts to reduce exposure to risk factors and to optimize childhood pertussis vaccination coverage.

Keywords: infant; pertussis; pneumonia; vaccination; whooping cough.

© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America.

Figures

Figure 1.
Figure 1.
Cumulative age distribution of children with severe or very severe pneumonia by pertussis infection status as determined by polymerase chain reaction (PCR) results. A, Children with a positive PCR result for pertussis (n = 53). B, Children whose PCR results were negative (n = 4120). Pertussis-positive children were significantly younger than pertussis-negative children (median, 2 vs 7 months; P = .01, logistic regression adjusted for site, restricted to sites in Africa and Bangladesh where positive cases were found).

References

    1. Crowcroft NS, Stein C, Duclos P, Birmingham M. How best to estimate the global burden of pertussis? Lancet Infect Dis 2003; 3:413–8.
    1. Liu L, Oza S, Hogan D et al. . Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 2015; 385:430–40.
    1. Forsyth K, Plotkin S, Tan T, Wirsing von König CH. Strategies to decrease pertussis transmission to infants. Pediatrics 2015; 135:e1475–82.
    1. Levine OS, O'Brien KL, Deloria-Knoll M et al. . The Pneumonia Etiology Research for Child Health Project: a 21st century childhood pneumonia etiology study. Clin Infect Dis 2012; 54:S93–101.
    1. Deloria-Knoll M, Feikin DR, Scott JAG et al. . Identification and selection of cases and controls in the Pneumonia Etiology Research for Child Health project. Clin Infect Dis 2012; 54:S117–23.
    1. Scott JAG, Wonodi C, Moïsi JC et al. . The definition of pneumonia, the assessment of severity, and clinical standardization in the Pneumonia Etiology Research for Child Health study. Clin Infect Dis 2012; 54(suppl 2):S109–16.
    1. Cherian T, Mulholland EK, Carlin JB et al. . Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ 2005; 83:353–9.
    1. Hammitt LL, Murdoch DR, Scott JAG et al. . Specimen collection for the diagnosis of pediatric pneumonia. Clin Infect Dis 2012; 54(suppl 2):S132–9.
    1. Grant LR, Hammitt LL, Murdoch DR, O'Brien KL, Scott JA. Procedures for collection of induced sputum specimens from children. Clin Infect Dis 2012; 54:S140–5.
    1. Murdoch DR, O'Brien KL, Driscoll AJ, Karron RA, Bhat N. Laboratory methods for determining pneumonia etiology in children. Clin Infect Dis 2012; 54(suppl 2):S146–52.
    1. Murdoch D, Morpeth S, Hammitt L. Microscopic analysis and quality assessment of induced sputum from children with pneumonia in the PERCH Study. Clin Infect Dis 2017. In press.
    1. Antila M, He Q, de Jong C et al. . Bordetella holmesii DNA is not detected in nasopharyngeal swabs from Finnish and Dutch patients with suspected pertussis. J Med Microbiol 2006; 55:1043–51.
    1. Winter K, Zipprich J, Harriman K et al. . Risk factors associated with infant deaths from pertussis: a case-control study. Clin Infect Dis 2015; 61:1099–106.
    1. Tiwari TSP, Baughman AL, Clark TA. First pertussis vaccine dose and prevention of infant mortality. Pediatrics 2015; 135:990–9.
    1. Paddock CD, Sanden GN, Cherry JD et al. . Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis 2008; 47:328–38.
    1. Berger JT, Carcillo JA, Shanley TP et al. . Critical pertussis illness in children: a multicenter prospective cohort study. Pediatr Crit Care Med 2013; 14:356–65.
    1. Sawal M, Cohen M, Irazuzta JE et al. . Fulminant pertussis: a multi-center study with new insights into the clinico-pathological mechanisms. Pediatr Pulmonol 2009; 44:970–80.
    1. Muloiwa R, Dube FS, Nicol MP, Zar HJ, Hussey GD. Incidence and diagnosis of pertussis in South African children hospitalized with lower respiratory tract infection. Pediatr Infect Dis J 2016; 35:611–6.
    1. Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling AC. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA 2011; 305:576–84.
    1. Haberling DL, Holman RC, Paddock CD, Murphy TV. Infant and maternal risk factors for pertussis-related infant mortality in the United States, 1999 to 2004. Pediatr Infect Dis J 2009; 28:194–8.
    1. Sheridan SL, Ware RS, Grimwood K, Lambert SB. Reduced risk of pertussis in whole-cell compared to acellular vaccine recipients is not confounded by age or receipt of booster-doses. Vaccine 2015; 33:5027–30.
    1. Fulton TR, Phadke VK, Orenstein WA, Hinman AR, Johnson WD, Omer SB. Protective effect of contemporary pertussis vaccines: a systematic review and meta-analysis. Clin Infect Dis 2016; 62:1100–10.
    1. Zar HJ, Barnett W, Stadler A, Gardner-Lubbe S, Myer L, Nicol MP. Aetiology of childhood pneumonia in a well vaccinated South African birth cohort: a nested case-control study of the Drakenstein Child Health Study. Lancet Respir Med 2016; 4:463–72.
    1. Loeffelholz M. Towards improved accuracy of Bordetella pertussis nucleic acid amplification tests. J Clin Microbiol 2012; 50:2186–90.
    1. Pittet LF, Posfay-Barbe KM. Bordetella holmesii: still emerging and elusive 20 years on. Microbiol Spectr 2016; 4.
    1. Cox HC, Jacob K, Whiley DM et al. . Further evidence that the IS481 target is suitable for real-time PCR detection of Bordetella pertussis. Pathology 2013; 45:202–3.
    1. Cherry JD, Tan T, Wirsing von König C-H et al. . Clinical definitions of pertussis: summary of a Global Pertussis Initiative roundtable meeting, February 2011. Clin Infect Dis 2012; 54:1756–64.
    1. van den Brink G, Wishaupt JO, Douma JC, Hartwig NG, Versteegh FGA. Bordetella pertussis: an underreported pathogen in pediatric respiratory infections, a prospective cohort study. BMC Infect Dis 2014; 14:526.
    1. Kline JM, Lewis WD, Smith EA, Tracy LR, Moerschel SK. Pertussis: a reemerging infection. Am Fam Physician 2013; 88:507–14.
    1. Wymann MN, Richard J-L, Vidondo B, Heininger U. Prospective pertussis surveillance in Switzerland, 1991–2006. Vaccine 2011; 29:2058–65.
    1. Van Rie A, Wendelboe AM, Englund JA. Role of maternal pertussis antibodies in infants. Pediatr Infect Dis J 2005; 24:S62–5.
    1. Casano P, Odena MP, Cambra FJ, Martín JM, Palomeque A. Bordetella pertussis infection causing pulmonary hypertension. Arch Dis Child 2002; 86:453.
    1. Hoppe JE. Neonatal pertussis. Pediatr Infect Dis J 2000; 19:244–7.
    1. Winter K, Harriman K, Zipprich J et al. . California pertussis epidemic, 2010. J Pediatr 2012; 161:1091–6.
    1. Kohn JL, Fischer AE, Marks HH. Case fatality in infants and children with pertussis, 1942–1946. Pediatrics 1950; 5:840–52.
    1. Nicoll A, Gardner A. Whooping cough and unrecognised postperinatal mortality. Arch Dis Child 1988; 63:41–7.
    1. Crowcroft NS, Booy R, Harrison T et al. . Severe and unrecognised: pertussis in UK infants. Arch Dis Child 2003; 88:802–6.
    1. Eberhardt CS, Blanchard-Rohner G, Lemaître B et al. . Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis. Clin Infect Dis 2016; 62:829–36.

Source: PubMed

3
Abonnere